Frequency of CYP2D6* 3 and* 4 and metabolizer phenotypes in three mestizo Peruvian populations
AT Alvarado, R Ybáñez Julca, AM Muñoz… - 2021 - repositorio.uchile.cl
Wild type genotypes (CYP2D6) and their allelic variants have been described in a sample of
a Peruvian mestizo population. The global allele frequency was 0.015 for CYP2D6* 3 and …
a Peruvian mestizo population. The global allele frequency was 0.015 for CYP2D6* 3 and …
[PDF][PDF] Frequency of CYP1A1* 2A polymorphisms and deletion of the GSMT1 gene in a Peruvian mestizo population
AT Alvarado, AM Muñoz, MS Bartra… - …, 2021 - pharmacia.pensoft.net
The polymorphic variants of CYP1A1 and the deletion of GSTM1 are present in the Peruvian
mestizo population. Wild type and mutated genotypes (WT/* 2A and* 2A/* 2A) were …
mestizo population. Wild type and mutated genotypes (WT/* 2A and* 2A/* 2A) were …
[PDF][PDF] Serum monitoring of carbamazepine in patients with epilepsy and clinical implications. Pharmacia 69 (2): 401–406
Carbamazepine is a drug with a narrow therapeutic range that requires clinical monitoring,
since its toxic effects are not easily predictable, and the therapeutic level can vary. Our study …
since its toxic effects are not easily predictable, and the therapeutic level can vary. Our study …
Interacciones farmacocinéticas de la azitromicina e implicación clínica
M Saravia Bartra, R Losno García… - Revista Cubana de …, 2021 - scielo.sld.cu
Objetivos: Revisar e integrar la información sobre las interacciones farmacocinéticas de la
azitromicina que se prescriben en el tratamiento ambulatorio de la COVID-19 en el Perú, y …
azitromicina que se prescriben en el tratamiento ambulatorio de la COVID-19 en el Perú, y …
[PDF][PDF] Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru
AT Alvarado, AM Muñoz, N Varela… - …, 2023 - pharmacia.pensoft.net
Epilepsy is the most common neurological disorder with a worldwide incidence of 20% and
a treatment failure rate of 25–30%. The fluctuation in serum levels, efficacy and safety of …
a treatment failure rate of 25–30%. The fluctuation in serum levels, efficacy and safety of …
Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia
S Giraldo-Ocampo, L Diaz-Ordoñez, YK Silva-Cuero… - Medicine, 2023 - journals.lww.com
Alleles in the VKORC1, CYP2C9, and CYP4F2 genes can influence Warfarin dose
requirement. We aimed to determine the frequency of the polymorphisms in these genes in …
requirement. We aimed to determine the frequency of the polymorphisms in these genes in …
[PDF][PDF] In vitro therapeutic equivalence of two multisource (generic) formulations of sodium phenytoin (100 mg) available in Peru
AT Alvarado, AM Muñoz, JM Miyasato… - Dissolut …, 2020 - researchgate.net
This in vitro study evaluated the therapeutic equivalence of two multisource (generic)
formulations of 100-mg phenytoin as immediate-release tablets available in the Peruvian …
formulations of 100-mg phenytoin as immediate-release tablets available in the Peruvian …
[HTML][HTML] Estudio del índice nivel/dosis de la fenitoína en pacientes epilépticos voluntarios de Mérida
ÁT Alvarado, M Pineda, L Cervantes… - Revista Médica Clínica …, 2020 - Elsevier
Introducción La fenitoína es usada con mucha frecuencia en nuestro medio, por lo que se
requiere hacer estudios de monitorización terapéutica, que contribuya a minimizar los …
requiere hacer estudios de monitorización terapéutica, que contribuya a minimizar los …
[PDF][PDF] Phenytoin concentration in people with epilepsy: A comparative study in serum and saliva. Pharmacia 69 (3): 809–814
A Alvarado, G García, A Morales, G Paredes, M Mora… - 2022 - academia.edu
In clinical practice, therapeutic drug monitoring (TDM) makes it possible to measure the
concentration of drugs in serum or saliva, the purpose of which is to reduce adverse effects …
concentration of drugs in serum or saliva, the purpose of which is to reduce adverse effects …
[PDF][PDF] Phenytoin concentration in people with epilepsy: a comparative study in serum and saliva
A Alvarado, G García, A Morales, G Paredes… - …, 2022 - pharmacia.pensoft.net
In clinical practice, therapeutic drug monitoring (TDM) makes it possible to measure the
concentration of drugs in serum or saliva, the purpose of which is to reduce adverse effects …
concentration of drugs in serum or saliva, the purpose of which is to reduce adverse effects …